University Multiprofile Hospital for Active Treatment Aleksandrovska

Sofia 1431

1 studies enrolling now · 5 studies all time

What they study most

Mild Thrombocytopenia, Moderate Thrombocytopenia, Myelofibrosis, Non-segmental Vitiligo, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Primary Myelofibrosis, Vitiligo

Studies at this site

• A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia — Recruiting now
• Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis — Running, not enrolling
• Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2) — Completed
• Assess the Long Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo — Completed
• A Study of Momelotinib Versus Danazol in Symptomatic and Anemic Myelofibrosis Participants (MOMENTUM) — Completed